Bladder cancer
Conditions
Interventions
Standard lymphadectomy will be performed. Before surgery, the near-infrared dye ICG:HSA will be injected and lymphatic pathways and lymph nodes will be visualized non-invasively using our experimental
Sponsors
Leiden University Medical Center (LUMC)
Eligibility
Inclusion criteria
Inclusion criteria: Bladder cancer patients planned to undergo a wide local excision and lymphadenectomy.
Exclusion criteria
Exclusion criteria: 1. History of allergy to iodine, shellfish, indocyanine green or human serum albumin; 2. Pregnancy; 3. Presence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification rate, defined as the proportion of patients in whom sentinel and non-sentinel lymph nodes was identified percutaneously with the fluorescent signal of ICG:HSA. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Median number of lymph nodes identified with ICG:HSA; 2. Sensitivity: percentage of patients in whom fluorescent lymph nodes were identified of the total patients with identified sentinel lymph nodes by standard SNB technique; 3. signal-to-background ratio. | — |
Contacts
Public ContactC.J.H. Velde, van de
Leiden University Medical Center (LUMC), Department of Surgical Oncology, P.O. Box 9600
Outcome results
None listed